{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:04:09Z","timestamp":1784178249271,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016627","name":"Anticancer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infection is a common and often fatal complication in cancer patients. Notably, cancer patients account for up to 21% of all sepsis cases. Furthermore, sepsis is present in 30% of all deaths among those hospitalized with cancer. However, comprehensive antimicrobial resistance (AMR) surveillance data specific to this population are lacking. This gap hinders the effectiveness of antimicrobial stewardship programs (ASPs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated bacterial distribution and AMR patterns in Chinese cancer patients to inform empirical therapy and ASPs. This multicenter retrospective study collected hospital-wide clinical isolates and drug-susceptibility data from 23 cancer centers during 2016\u20132023. All procedures followed standardized methods in accordance with national surveillance protocols and Clinical and Laboratory Standards Institute guidelines. Data were subjected to dual validation using WHONET and a domestically developed big-data system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Gram-negative 75.4% (270,609), Gram-positive 24.6% (88,177) of 358,786 isolates from cancer patients in these oncology centers. Predominant Gram-negative species were\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      ,\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      ,\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      ,\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      , and\n                      <jats:italic>Enterobacter cloacae<\/jats:italic>\n                      .\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      exhibited low imipenem resistance (0.9\u20131.5%) with a recent increase (2021\u20132023: APC = 16.57%,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001).\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      showed stable imipenem resistance (1.6\u20131.9%) but increasing meropenem resistance (0.4\u20131.6%).\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      imipenem resistance declined (12.5\u20137.9%), while meropenem resistance remained stable (7.0\u20135.2%); while\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      carbapenem resistance increased substantially (imipenem: 9.6\u201318.4%; meropenem: 4.7\u201318.8%). Leading Gram-positive organisms were\n                      <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      ,\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      ,\n                      <jats:italic>Enterococcus faecalis<\/jats:italic>\n                      , and\n                      <jats:italic>Staphylococcus haemolyticus<\/jats:italic>\n                      . Methicillin-resistant\n                      <jats:italic>Staphylococcus aureus (MRSA)<\/jats:italic>\n                      resistance declined over five years, with no resistance to linezolid, vancomycin, or teicoplanin.\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      spp. gradually developed resistance to last-resort antibiotics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Carbapenem resistance among common Gram-negatives in cancer patients was below national averages. MRSA and enterococcal resistance were also below national levels. These findings underscore the unique resistance epidemiology in oncology, supporting tailored guidelines and dedicated surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1848531","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:20:31Z","timestamp":1784175631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of pathogen resistance in Chinese cancer patients based on bacterial resistance surveillance in 23 provinces, 2016\u20132023"],"prefix":"10.3389","volume":"17","author":[{"given":"Yingnan","family":"Ju","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Clinical College","place":["Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tianjin Medical University Cancer Institute and Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sun Yat-sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Fudan University Shanghai Cancer Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Peking University Cancer Hospital and Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hebei Tumor Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hunan Cancer Hospital","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hubei Cancer Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keliang","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tianjin Medical University Cancer Institute and Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-rong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sun Yat-sen University Cancer Center","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingguang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanxi Cancer Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guangxi Medical University Cancer Hospital","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanling","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Sichuan Cancer Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University, School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Fourth Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhejiang Cancer Hospital","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Jilin Provincial Tumor Hospital","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Fujian Cancer Hospital","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Anhui Provincial Cancer Hospital","place":["Hefei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhe","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Gansu Provincial Cancer Hospital","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuliang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Jiangsu Cancer Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2019an","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Jiangxi Cancer Hospital","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Hangzhou Cancer Hospital","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Nantong Tumor Hospital","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Baotou Cancer Hospital","place":["Baotou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewu","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Affiliated Cancer Hospital of Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The Third Affiliated Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tianjin Medical University Cancer Institute and Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3322\/caac.21462","article-title":"Update on infection control practices in cancer hospitals.","volume":"68","author":"Ariza-Heredia","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","article-title":"Global disparities of cancer and its projected burden in 2050.","volume":"7","author":"Bizuayehu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.18231\/j.ijmmtd.29077.1763543767","article-title":"Culture and sensitivity in cancer patients presenting with sepsis.","volume":"11","author":"Boswal","year":"2025","journal-title":"IP Intern. J. Med. Microbiol. Trop. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/aac.40.2.503","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.","volume":"40","author":"Carratala","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide.","volume":"156","author":"Filho","year":"2025","journal-title":"Int. J. Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s44280-025-00092-0","article-title":"Antimicrobial resistance profile of clinical isolates from hospitals across China: CHINET 2024 surveillance report.","volume":"3","author":"Guo","year":"2025","journal-title":"One Health Adv."},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022.","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1075185","DOI":"10.3389\/fcimb.2022.1075185","article-title":"A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"ofae678","DOI":"10.1093\/ofid\/ofae678","article-title":"Efficiency of a long-term infectious diseases consultation and antimicrobial stewardship program at a japanese cancer center: An interrupted time-series analysis.","volume":"11","author":"Itoh","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12879-020-05181-6","article-title":"Nosocomial infections due to multidrug-resistant bacteria in cancer patients: A six-year retrospective study of an oncology Center in Western China.","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/s1473-3099(20)30003-7","article-title":"The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later.","volume":"20","author":"Laxminarayan","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7861\/clinmed.2023-0408","article-title":"Patients with cancer and sepsis trials: An unfair representation?","volume":"23","author":"Nelmes","year":"2023","journal-title":"Clin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"lxaf102","DOI":"10.1093\/jambio\/lxaf102","article-title":"Understanding the prevalence, antimicrobial resistance, and public health challenges of Acinetobacter baumannii in India and China.","volume":"136","author":"Pathoor","year":"2025","journal-title":"J. Appl. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1093\/cid\/ciu612","article-title":"Antibiotic-resistant gram-negative bacterial infections in patients with cancer.","volume":"59","author":"Perez","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1093\/cid\/ciu639","article-title":"Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients.","volume":"59","author":"Perfect","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41579-021-00620-w","article-title":"From the soil to the clinic: The impact of microbial secondary metabolites on antibiotic tolerance and resistance.","volume":"20","author":"Perry","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41375-019-0547-0","article-title":"Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy.","volume":"34","author":"Rashidi","year":"2020","journal-title":"Leukemia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.","volume":"55","author":"Taur","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: A narrative review.","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/jci43918","article-title":"Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.","volume":"120","author":"Ubeda","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/pharmaceutics15020518","article-title":"Correlation between antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the antimicrobial stewardship program in Japan.","volume":"15","author":"Ueda","year":"2023","journal-title":"Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"Cd003295","DOI":"10.1002\/14651858.CD003295.pub3","article-title":"Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.","volume":"2013","author":"van de Wetering","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"Cd003295","DOI":"10.1002\/14651858.CD003295.pub4","article-title":"Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.","volume":"10","author":"van den Bosch","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e099847","DOI":"10.1136\/bmjopen-2025-099847","article-title":"Epidemiological investigation and patterns of antimicrobial use in multidrug-resistant bacteria at a tertiary hospital: A retrospective cohort study.","volume":"15","author":"Wang","year":"2025","journal-title":"BMJ Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0146825","DOI":"10.1128\/spectrum.01468-25","article-title":"Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi. China.","volume":"13","author":"Xu","year":"2025","journal-title":"Microbiol. Spectr."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1848531\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:20:32Z","timestamp":1784175632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1848531\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":25,"alternative-id":["10.3389\/fmicb.2026.1848531"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1848531","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1848531"}}